Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DaHuang GanTsao Tang is a traditional Chinese herbal formula (TCM) consisting of two primary botanical components: *Rheum palmatum* (Rhubarb) and *Glycyrrhiza uralensis* (Licorice). Historically utilized in East Asian medicine to treat constipation and gastrointestinal disharmony, the formula is currently being evaluated in clinical trials for its potential to alleviate appetite loss (anorexia) and improve quality of life in patients with late-stage cancer. The therapeutic effects are attributed to the synergistic action of Rhubarb-derived anthraquinones, which stimulate intestinal motility, and Licorice-derived glycyrrhizin, which provides anti-inflammatory and cytoprotective benefits. In the context of cancer cachexia, the formula is hypothesized to resolve 'block and repulsion' states to improve nutritional intake and overall patient well-being.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dahuang gancao tang.